
### [MONDO:0017359](http://purl.obolibrary.org/obo/MONDO_0017359)
**Label:** 3-methylglutaconic aciduria

**Subclasses:** [MONDO:0014561](http://purl.obolibrary.org/obo/MONDO_0014561) (3-methylglutaconic aciduria with cataracts, neurologic involvement and neutropenia), [MONDO:0010543](http://purl.obolibrary.org/obo/MONDO_0010543) (Barth syndrome), [MONDO:0012435](http://purl.obolibrary.org/obo/MONDO_0012435) (3-methylglutaconic aciduria type 5), [MONDO:0009610](http://purl.obolibrary.org/obo/MONDO_0009610) (3-methylglutaconic aciduria type 1), [MONDO:0009787](http://purl.obolibrary.org/obo/MONDO_0009787) (3-methylglutaconic aciduria type 3), [MONDO:0009611](http://purl.obolibrary.org/obo/MONDO_0009611) (3-methylglutaconic aciduria type 4), [MONDO:0013875](http://purl.obolibrary.org/obo/MONDO_0013875) (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome), [MONDO:0014988](http://purl.obolibrary.org/obo/MONDO_0014988) (3-methylglutaconic aciduria, type Viii; MGCA8), 

**Corr. equiv. classes:** [Orphanet:111](http://www.orpha.net/ORDO/Orphanet_111), [OMIM:250951](http://purl.obolibrary.org/obo/OMIM_250951), [OMIM:616271](http://purl.obolibrary.org/obo/OMIM_616271), [Orphanet:67046](http://www.orpha.net/ORDO/Orphanet_67046), [Orphanet:67048](http://www.orpha.net/ORDO/Orphanet_67048), [Orphanet:67047](http://www.orpha.net/ORDO/Orphanet_67047), [OMIM:258501](http://purl.obolibrary.org/obo/OMIM_258501), [OMIM:617248](http://purl.obolibrary.org/obo/OMIM_617248), [Orphanet:66634](http://www.orpha.net/ORDO/Orphanet_66634), [OMIM:610198](http://purl.obolibrary.org/obo/OMIM_610198), [Orphanet:352328](http://www.orpha.net/ORDO/Orphanet_352328), [Orphanet:445038](http://www.orpha.net/ORDO/Orphanet_445038), [OMIM:302060](http://purl.obolibrary.org/obo/OMIM_302060), [OMIM:250950](http://purl.obolibrary.org/obo/OMIM_250950), [OMIM:614739](http://purl.obolibrary.org/obo/OMIM_614739), 

**Class expressions from DL-Learner:**

- [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) 73.33%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) 73.33%
- [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 73.33%
- [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 73.33%
- [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 73.33%
- [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 73.33%
- [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) 73.33%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) 73.33%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 73.33%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 73.33%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) 73.33%
- [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 70.10%
- [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 70.10%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) and [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 70.10%
- [HP:0003535](http://purl.obolibrary.org/obo/HP_0003535) (3-Methylglutaconic aciduria) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 70.09%


